Kirke Weaver's most recent trade in Organon & Co. was a trade of 8,045 Common Stock done at an average price of $9.2 . Disclosure was reported to the exchange on May 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Purchase of securities on an exchange or from another person at price $ 9.20 per share. | 06 May 2025 | 8,045 | 52,489 | - | 9.2 | 74,054 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 181,518 | 181,518 | - | - | Stock Option (right to buy) | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 36,937 | 36,937 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 7,757 | 15,514 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 7,757 | 36,917 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 6,200 | 40,907 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 6,200 | 6,200 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,294 | 0 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,294 | 45,668 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 3,125 | 42,265 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 3,125 | 0 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 2,210 | 34,707 | - | 14.5 | 32,067 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 1,767 | 39,140 | - | 14.5 | 25,639 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 1,224 | 44,444 | - | 14.5 | 17,760 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 891 | 41,374 | - | 14.5 | 12,928 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 1,248 | 29,516 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 1,248 | 0 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. | 04 May 2024 | 356 | 29,160 | - | 19.6 | 6,981 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 6,200 | 12,400 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 6,200 | 27,801 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 4,294 | 4,294 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 4,294 | 22,825 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 3,125 | 3,125 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 3,125 | 29,159 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. | 31 Mar 2024 | 1,767 | 26,034 | - | 18.8 | 33,220 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. | 31 Mar 2024 | 1,224 | 21,601 | - | 18.8 | 23,011 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. | 31 Mar 2024 | 891 | 28,268 | - | 18.8 | 16,751 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 95,315 | 95,315 | - | - | Stock Option (right to buy) | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 23,271 | 23,271 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 4,957 | 0 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 4,957 | 20,138 | - | - | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.04 per share. | 28 Feb 2024 | 1,607 | 18,531 | - | 18.0 | 28,990 | Common Stock |
Organon & Co. | Weaver Kirke | Gen. Counsel & Corp. Secy. | Purchase of securities on an exchange or from another person at price $ 18.36 per share. | 22 Feb 2024 | 2,720 | 15,181 | - | 18.4 | 49,939 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 1,246 | 12,816 | - | - | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 1,246 | 1,248 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.24 per share. | 04 May 2023 | 355 | 12,461 | - | 24.2 | 8,605 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,099 | 0 | - | - | Restricted stock units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,099 | 11,884 | - | - | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.63 per share. | 01 May 2023 | 314 | 11,570 | - | 24.6 | 7,734 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 66,793 | 66,793 | - | - | Stock Option (right to buy) | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 7,419 | 14,838 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 7,419 | 12,900 | - | 0 | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 31 Mar 2023 | 2,115 | 10,785 | - | 23.1 | 48,835 | Common Stock |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 4,616 | 0 | - | - | Restricted Stock Units | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 4,616 | 6,912 | - | - | Common Stock | |
Organon & Co. | Kirke Weaver | Gen. Counsel & Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.09 per share. | 28 Feb 2023 | 1,431 | 5,481 | - | 25.1 | 35,904 | Common Stock |